Impact of ribavirin dose on retreatment of chronic hepatitis C patients

doi:10.3748/wjg.v18.i23.2966

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 23

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2363)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-2) series, Tables (1-2) series.

Item

Count

PDF

257

HTML

1803

Figures (1-2)

147

Tables (1-2)

156

Sum=2363

Jun 21, 2012 (publication date) through Apr 27, 2024

Times Cited of This Article

Times Cited (1)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Jun 21, 2012; 18(23): 2966-2972
Published online Jun 21, 2012. doi: 10.3748/wjg.v18.i23.2966

Full Size Figure Download Figure

Figure 2 Predictive value of complete early virological response. Among 46 patients with complete early virological response (cEVR), 25 (54%) patients achieved an sustained virological response (SVR) and 21 (46%) were non-responders (17 patients had a relapse and 4 patients had a non-response). Positive predictive value of cEVR for SVR = 54% (P = 0.003). Negative predictive value of cEVR for SVR = 100% (P = 0.003). HCV: Hepatitis C virus; NR: Non response.

Citation: Stern C, Martinot-Peignoux M, Ripault MP, Boyer N, Castelnau C, Valla D, Marcellin P. Impact of ribavirin dose on retreatment of chronic hepatitis C patients. World J Gastroenterol 2012; 18(23): 2966-2972
URL: https://www.wjgnet.com/1007-9327/full/v18/i23/2966.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i23.2966